WinSanTor

WinSanTor

Growth Stage

Ensuring no one suffers from Peripheral Neuropathy.

Ensuring no one suffers from Peripheral Neuropathy.

Overview

Raised this Round: Raised: $596,649

Total Commitments ($USD)

Platform

Wefunder

Start Date

09/27/2018

Close Date

03/20/2019

Min. Goal
$300,000
Max. Goal
$1,070,000
Min. Investment

$500

Security Type

SAFE

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$70,000,000

Discount

25%

Year Founded

2011

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Location

San Diego, California

Winsantor is here to make sure that no one suffers from peripheral neuropathy (PN). PN affects 1 in 15 people in the US, and it’s when the nerves die due to disease, injuries, cancer, or genetic diseases. There is currently no treatment -- just drugs that help reduce the pain. Winsantor, however, is currently in trials that show they be on track to reverse the disease, both biologically and functionally. So far, over $30M of non-dilutive funding has driven R&D; they are currently entering Phase 2 of early efficacy studies; and they aim to have their drug approved by 2021 to start helping -- and changing -- the lives of those who are affected.
Create a free account today to gain access to KingsCrowd analytics.

Raise History

Offering Name Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
WinSanTor 04/28/2024 Wefunder $500,000,000 $193,502 SAFE Funded RegCF
WinSanTor 04/27/2020 StartEngine $75,000,000 $32,651 Convertible Note Not Funded RegCF
WinSanTor 03/19/2019 Wefunder $70,000,000 $596,649 SAFE Funded RegCF
Create a free account today to gain access to KingsCrowd analytics.

Revenue History

Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.

Valuation History

Price per Share History

Note: Share prices shown in earlier rounds may not be indicative of any stock splits.

Employee History

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.
Add to portfolio
WinSanTor on Wefunder
Platform: Wefunder
Security Type: SAFE
Valuation: $70,000,000

Follow company

Follow WinSanTor on Wefunder

Buy WinSanTor's Deal Report

Warning: according to the close date for this deal, WinSanTor may no longer be accepting investments.

WinSanTor Deal Report

Get KingsCrowd’s comprehensive report on WinSanTor including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether WinSanTor is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the WinSanTor deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge